Alkermes, Inc.Cambridge, MA, United States (NASDAQ (GS): ALKS)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Alkermes Financial Statements

Alkermes Financial Information

Company Type Public
Headquarters
Fiscal Year-End March
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Alkermes Income Statement

  2008 2007 2006
Revenue ($ mil.) 240.7 240.0 166.6
Gross Profit ($ mil.) 200.0 194.8 143.1
Operating Income ($ mil.) (2.8) 11.0 13.7
Total Net Income ($ mil.) 167.0 9.4 3.8
Diluted EPS (Net Income) 1.62 0.09 0.04
More Alkermes financial information

Alkermes Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 80.0 62.4 50.8
Gross Profit ($ mil.) 65.7 48.6 43.3
Operating Income ($ mil.) 31.5 (17.8) (2.4)
Total Net Income ($ mil.) 29.7 (18.4) 168.9
Diluted EPS (Net Income) 0.31 (0.16) 1.62
More Alkermes financial information

Alkermes Stock Quote & Chart

09/05/08 15:00:16 EST • NASDAQ • 13.43 • Decreased by -0.2200 • Decreased by -1.6117 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Alkermes Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 6.00 3.68 1.55
Price/Earnings Ratio 8.50 15.08 15.52
Price/Book Ratio 4.60 2.95 1.48
Price/Cash Flow Ratio 15.28 12.46 9.60
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Alkermes Financial Ratios

Alkermes Competitive Intelligence

Bristol-Myers Squibb DURECT Johnson & Johnson
Annual Sales ($ mil.) 19,348.0 30.7 61,095.0
Employees 42,000 -- 119,200
Market Cap ($ mil.) 43,230.6 436.7 198,797.7

Competitive Landscape